Tay Cities Innovation Hub
Get in touch
Summary
State-of-the-art facilities to foster research and collaboration
Robertson is delivering the Tay Cities Regional Innovation Hub which will not only provide training and support for biotechnology students and early-careers professionals, but also foster innovation and intercommunication between industry and academic partners.
It forms a new BioMedical Cluster, along with the MedTech R&D Unit, completed in 2024.
Key facts
These projects have been independently assessed to have an economic impact predicted to be:
281
biomedical jobs created by 2033
800
new jobs by 2053
£190 million
benefit to the local economy by 2053
Tay Cities Innovation Hub
We are creating a new 4,790m2 three-storey, two-wing facility that is a collaborative initiative between the University of Dundee, Scottish Enterprise, and other key stakeholders, which will foster innovation and high growth in the biomedical industry.
The development responds to the increasing demand for biotechnology and pharmaceutical research and development facilities in Scotland.
This world-class life sciences environment will attract innovative, entrepreneurial expertise, so that high-growth companies can be formed, providing new treatments and technologies, as well as jobs for the region.
The hub has a modular design, enabling companies to lease the right amount of laboratory and office space they need to grow.
MedTech R&D Unit - Wilson House
Robertson has developed a unique medical technologies innovation environment, through a refurbishment at Ninewells Hospital and Medical School.
Refurbished in 2024, Wilson House in Dundee Medipark (near Ninewells), now brings together the University, NHS, and industry to enable new technologies to move quickly from prototyping to commercialization to adoption by the NHS, ultimately generating new wealth for the region and improving health outcomes.
This new MedTech R&D unit offers unique capabilities such as cadaveric facilities, state of the art imaging and ISO-certified prototype production to pre-clinical level.
Community impact
In delivering these projects, we will take a proactive approach to inclusive growth to unlock opportunities for community participation and engagement, local employment and local supply chains, and participation from under-represented groups in the regional life sciences sector.
